Hi, I am a graduate student and I have just heard Roche stop supporting the 454 pyrosequencing platform by 2016. Our university has to buy another Next-gen sequencing platform.
I was surprised. Does anyone know what happened? Two year ago, I think 454 pyrosequencing occupied >50% market. I don't think this is about business. Also, lots of publications use pyrosequencing
Are they gonna develop new sequencing technologies? Is pyrosequencing a technological dead end? Is Illumina a good choice?
Ben
I was surprised. Does anyone know what happened? Two year ago, I think 454 pyrosequencing occupied >50% market. I don't think this is about business. Also, lots of publications use pyrosequencing
Are they gonna develop new sequencing technologies? Is pyrosequencing a technological dead end? Is Illumina a good choice?
Ben
Comment